| Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal L Wynants, B Van Calster, GS Collins, RD Riley, G Heinze, E Schuit, ... bmj 369, 2020 | 3114 | 2020 |
| Thrombus aspiration during primary percutaneous coronary intervention T Svilaas, PJ Vlaar, IC van der Horst, GFH Diercks, BJGL de Smet, ... New England journal of medicine 358 (6), 557-567, 2008 | 1493 | 2008 |
| Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow … PJ Vlaar, T Svilaas, IC van der Horst, GFH Diercks, ML Fokkema, ... The Lancet 371 (9628), 1915-1920, 2008 | 1276 | 2008 |
| Coronary angiography after cardiac arrest without ST-segment elevation JS Lemkes, GN Janssens, NW van der Hoeven, LSD Jewbali, EA Dubois, ... New England Journal of Medicine 380 (15), 1397-1407, 2019 | 491 | 2019 |
| Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial ICC van der Horst, F Zijlstra, AWJ van't Hof, CJM Doggen, MJ de Boer, ... Journal of the American College of Cardiology 42 (5), 784-791, 2003 | 390 | 2003 |
| Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial … PJ Vlaar, KD Mahmoud, DR Holmes, G Van Valkenhoef, HL Hillege, ... Journal of the American College of Cardiology 58 (7), 692-703, 2011 | 369 | 2011 |
| Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment–elevation myocardial infarction treated with percutaneous coronary … JR Timmer, M Hoekstra, MWN Nijsten, ICC van der Horst, JP Ottervanger, ... Circulation 124 (6), 704-711, 2011 | 304 | 2011 |
| Pantoprazole in patients at risk for gastrointestinal bleeding in the ICU M Krag, S Marker, A Perner, J Wetterslev, MP Wise, JC Schefold, F Keus, ... New England Journal of Medicine 379 (23), 2199-2208, 2018 | 297 | 2018 |
| Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria J Koeze, F Keus, W Dieperink, ICC Van der Horst, JG Zijlstra, ... BMC nephrology 18, 1-9, 2017 | 244 | 2017 |
| Prognostic value of admission glucose in non-diabetic patients with myocardial infarction JR Timmer, ICC van der Horst, JP Ottervanger, JPS Henriques, ... American heart journal 148 (3), 399-404, 2004 | 229 | 2004 |
| Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure M Yin, ICC van der Horst, JP van Melle, C Qian, WH van Gilst, HHW Silljé, ... American Journal of Physiology-Heart and Circulatory Physiology 301 (2 …, 2011 | 227 | 2011 |
| Hyperglycaemic index as a tool to assess glucose control: a retrospective study M Vogelzang, ICC van der Horst, MWN Nijsten Critical Care 8, 1-6, 2004 | 217 | 2004 |
| Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients AM Corstjens, JJM Ligtenberg, ICC van der Horst, R Spanjersberg, ... Critical Care 10, 1-7, 2006 | 207 | 2006 |
| Telomere length loss due to smoking and metabolic traits J Huzen, LSM Wong, DJ Van Veldhuisen, NJ Samani, AH Zwinderman, ... Journal of internal medicine 275 (2), 155-163, 2014 | 202 | 2014 |
| Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial CPH Lexis, ICC van der Horst, E Lipsic, WG Wieringa, RA de Boer, ... Jama 311 (15), 1526-1535, 2014 | 195 | 2014 |
| Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention … YL Gu, MA Kampinga, WG Wieringa, ML Fokkema, MW Nijsten, ... Circulation 122 (25), 2709-2717, 2010 | 187 | 2010 |
| Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study EN Klein Hesselink, MS Klein Hesselink, GH de Bock, RT Gansevoort, ... Journal of Clinical Oncology 31 (32), 4046-4053, 2013 | 186 | 2013 |
| Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised … APJ Vlaar, S de Bruin, M Busch, SA Timmermans, IE van Zeggeren, ... The Lancet Rheumatology 2 (12), e764-e773, 2020 | 181 | 2020 |
| Current use of vasopressors in septic shock TWL Scheeren, J Bakker, D De Backer, D Annane, P Asfar, EC Boerma, ... Annals of intensive care 9, 1-12, 2019 | 167 | 2019 |
| Metabolomics profile in depression: a pooled analysis of 230 metabolic markers in 5283 cases with depression and 10,145 controls M Bot, Y Milaneschi, T Al-Shehri, N Amin, S Garmaeva, GLJ Onderwater, ... Biological psychiatry 87 (5), 409-418, 2020 | 164 | 2020 |
